Life Sciences Archive » April, 2011

Life Sciences - April, 2011

213 articles

• Actelion Must Pay Asahi $550M In Fasudil Suit: Jury
• Ex-MedQuist CFO Settles SEC Suit Over Billing Fraud
• Accused Trader Seeks To Subpoena Lehman, Barclays
• Baxter IP Counsel Tapped For Chief Patent Judge Post
• How The FDA Can Compel Post-Marketing Studies
• Lilly, SEC Push Toward Deal In FCPA Probe
• Reed Smith Lures Tech Deals Pro From Gibson Dunn
• Getting Out Of The Eastern District Of Texas
• Expertly Navigating Federal Expert Disclosure Rules
• Celgene Sues Americord Over Stem Cell Marketing
• Shire Sues Sandoz Over Planned Generic Intuniv
• Allergan Hit With $212M Verdict In Botox Suit
• Researcher Renews CVS Fight Over Prescription Data
• EU Probes Cephalon, Teva Deal Over Generic Provigil
• FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan
• Merck To Abide By Discharge Diet To End Enviro Suit
• Davis Polk Reps Aetna In $600M Prodigy Health Buy
• Using Injunctions In 'Bet-The-Company' Litigation
• Weighing Generic Litigation In The ITC
• Par Pharmaceutical Settles Medicaid Suits For $154M
• Lilly Wins Order Banning Generic Cymbalta Sales
• Abbott Appeals $3.5M OT Ruling In 7th Circ.
• Genzyme Sues Over Endo's Bid To Sell Generic Renvela
• Asahi, Actelion Throw Final Punches In Fasudil IP Row
• Mayo Wins Trade Secrets Verdict Against Ex-Employee
• Duane Reade Settles Medicaid Fraud Suit
• Albemarle Hit With CWA Suit Over Pharma Production
• FOIA Request Filed As Avastin Safety Hearing Nears
• Patent Reform Lobbying Pays Big For Akin Gump
• Hospira, Others Sued Over Infusion Pump Patent
• FTC Orders Hikma To Shed Drugs For $112M Baxter Deal
• Cravath, Weil Rep J&J In $21B Deal To Buy Synthes
• BP, AstraZeneca Settle Suit Over Seed IP Sale
• High Court Mulls Vt. Limits On Use Of Drug Data
• Judge Zaps Palomar's Laser Hair Removal IP Claims
• Elan Targets Teva Again Over Generic Focalin XR
• $251M Animal Health Co. Merger Moves Forward
• Metro Med Workers Sentenced For $23M Medicare Fraud
• FedEx, Delta Sued Over Web Communication IP
• Genzyme Asks To Add New Patent To Arthritis Drug Suit
• Pharmacist Hits Omnicare With Meal Break Class Action
• FDA To Repackage E-Cigarettes As Tobacco Products
• Baxter, CSL Look To Nix County's Blood Plasma Suit
• WHPM Hit With $20M Suit Over Drug Test Kits
• Non-Spock Economics In Antitrust
• Mutual Sues West-Ward Over Gout Drug Patents
• AstraZeneca, Pozen Sue Dr. Reddy's Over Vimovo Patent
• St. Jude Wins $2.3B Verdict In Trade Secrets Trial
• Northgate Infringes Lexion Laparoscopy IP: Fed. Circ.
• Yaz, Similar Pills Tied To Higher Blood Clot Risks
• Plaintiffs Fear Retaliation In MiraLax Antitrust Suit
• Genentech Sues Sandoz Over Generic Valcyte
• Judge Nixes New Trial For Braun, Terumo Catheter Row
• Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara
• Fund Wants J&J To Pay Up For Faulty Hip Implants
• Cardinal Health Settles Kickback Claims For $8M
• FDA Cautions Lifetech Over Eyelash Growth Products
• Ciba Ends Combative Ads To Settle Bausch & Lomb Case
• New Equity Committee Sinks Point Blank Ch. 11 Plan
• Feds Seek Deal Time In $3M FDA Chemist Trading Case
• Sanofi Free To Appeal Genentech Patent Ruling
• GSK, Scottrade Settle IP Suits Over Navy Technology
• Shire Sues Mylan Over Intuniv Patents
• Wyeth, Dr. Reddy's Strike Deal Over Effexor Patents
• Certifying To Medical Necessity Under FDA
• Webvention Targets Merck, Others In Web Data IP Suit
• Feds Want GSK VP To Testify In Wellbutrin Case
• Aetna Loses Bid To Re-Enter Pfizer Off-Label MDL
• Bayer Sues Mylan Over Generic Yaz
• MetaMorphix Scores Ch. 7 Conversion
• Novartis Targets Teva Over Myfortic Patents
• No New Trial For Former InterMune CEO
• US Cracks Down On Prescription Drug Abuse
• Judge Tosses Most Claims In Medtronic Class Action
• Off-Label Use Of Novo Drug May Harm Patients: Study
• AstraZeneca Sued Over Nexium Bone Fracture Risks
• Texas Hospital Fights To Sink Medicare Fraud Suit
• 2nd Circ. Nixes Suit Over University's Medicare Bills
• Genzyme, Daiichi Sue Watson Over Generic Welchol
• Raising The Bar On Proving Damages
• Defense Absent As St. Jude Trade Secrets Trial Begins
• Caraco Investors Seek Class Cert. In Stock Price Suit
• Suits Force Celera's Hand On $344M Merger With Quest
• Allergan Targets Sandoz Over Generic Latisse
• McCarter Adds Patent Attorney From Foley & Lardner
• Synthes Confirms Potential $20B Acquisition By J&J
• AstraZeneca, P&G Dodge Prilosec OTC Antitrust Suit
• 'Love And Other Drugs' In Real Life
• Harmonizing FDA Foreign And Domestic Inspections
• Welcome To The New Law360
• Merck, J&J Strike Deal In Arthritis Drugs Dispute
• FDA Ducks ViroPharma Suit Over Generics Guidelines
• Biotech Co., Mintz Levin Settle Suit Over Patents
• CVS Pays $17.5M To End False Claims Act Suit
• UK To Ban Lethal Injection Drug Exports To US
• Cypress Sued Over Unapproved Cold Medication
• FDA Issues Safety Warning On Teva's Generic Prevacid
• FTC Must Break Up CVS Caremark: Consumer Groups
• Judge Blocks Par Pharma's Generic Treximet
• Wyeth, Orchid Reach Deal In Effexor Patent Fight
• UK Court Strikes Down Infosint Patent In Citalopram Suit
• UHS Demands More Info From Rival In Antitrust Suit
• Ex-InterMune CEO Gets House Arrest For Drug Claims
• Ex-GSK Lawyer Faces New Obstruction Indictment
• Genzyme Sues Seikagaku Over Synvisc-One Patent
• FDA Recalls Radiation Shield That Sheds Tungsten
• Axcan To Pay Up To $230M For Rival Mpex
• 1st Circ. Won't Rehear Puerto Rico Bank's Merger Suit
• Penumbra Pulls Aneurysm Device Over Deadly Defects
• Align Buy Of Dental Scan Co. Isn't Crooked, FTC Says
• JPML To Weigh Consolidation Of Darvocet Cases
• Arguments On Appeal: FTC V. Lundbeck
• Takeda Drops Suit Over Apotex's Actos ANDA
• Applying American Pipe In State Courts
• J&J Recalls 57K Bottles Of Topamax Over Odor
• HGS Fires Round 2 At Genentech Over Lupus Drug IP
• Bill Seeks To Temper FDA Oversight Of Drug Imports
• FDA Warns Philips Over Fatal Defibrillator Defects
• Zyprexa Payors Ask High Court For Shot At Eli Lilly
• FDA Must Improve Medical Device Oversight, GAO Says
• Vioxx MDL Attys Want 3 Firms Backing Fee Plan KO'd
• FDA Urged To Help Get Prandin Row To High Court
• Calif. Wades Into Sutter Health Insurance Fraud Suit
• Lawyers Trade Blows Over Asahi, Actelion Trial Conduct
• Braun Can't Dodge False Marking Claims On IV Fluids
• Judge Says Cordis Stent Infringes BSC Patent
• Quest's $344M Celera Buy Averts Antitrust Hurdle
• Feds Charge FrontPoint Trader In $30M Inside Tips Case
• Moog Infusion Pumps Face Class I Recall
• Schneider Seeks To Quash Rumors Of $30B Tyco Offer
• Bryan Cave Reps Silgan In $4B Graham Packaging Deal
• More Big-Money Bias Suits Coming, Plaintiffs Firm Says
• Inspire Investor Challenges $430M Merck Deal
• Parties Offer Bellwether Plan In NuvaRing MDL
• Ropes & Gray Nabs IP Litigator From Sidley
• Fresenius Dialysis Device Faces FDA Scrutiny
• Chem Rx Liquidation Plan Wins OK After Amendments
• Hologic Sues IZI Over Mammogram Cushion Patent
• Dewey Lures Tech Deals Pro From Fulbright
• Sidley Reps SXC In UMass Benefits Manager Pickup
• Purdue Sues Impax, Ranbaxy Over Generic OxyContin
• Revlimid Cancer Woes Spark FDA Safety Review
• Former US Rep. Stupak Joins Venable Policy Group
• Merck, Sun Pharma Form Generics Joint Venture
• Skadden Reps Endo In $2.9B American Medical Buy
• Judge Says No To Generic Amrix
• Nautilus Sues Wockhardt Over Cambia ANDA
• Abbott To Pay $52M To Norvir Direct Purchaser Class
• Pfizer Wins Approval Of Unit's $265M Asbestos Deal
• UK Court Shutters Merck's Cosopt Patent Fight
• Microsoft Sues DataTern Over Database Patents
• Obama Taps Former Trade Attorney For ITC Post
• Ex-Point Blank CEO Fights Deregistration Plan
• GSK Rival Barred From Infringing Aquafresh Mark
• False Marking Cases On Shaky Ground After BP Ruling
• No Sympathy For Off-Label Scripts Suits
• J&J Pays $78M To Settle Foreign Bribery Cases
• Judge Nixes Releases In Chem Rx Ch. 11 Plan
• FDA Blasts Mylan Suit Over Generic Lipitor Exclusivity
• 4-Partner Litigation Team Joins Gibson Dunn In NY
• Minsurg Infringement Claims Survive Dismissal Bid
• Alcon Sues Watson Over Vigamox Patents
• Shareholder Suits Over Genoptix Sale Consolidated
• Blinded Mexican Patients Can Bring US Suit: 9th Circ.
• Angiotech Wins US Approval Of Canada Restructuring
• Kaye Scholer Reps Novartis In $420M Elidel Sale
• Deformed Consent
• Judge Tosses Challenge To FDA Supplement Rules
• FDA Orders Seizure Of $6M In Products At Triad Plant
• Latham & Watkins Nets Wilson Sonsini IP Group
• Jury To Weigh Lost Profits In Neurontin Patent Fight
• Shire Sues Watson Again Over Adderall Patents
• Is It Material? Depends On Who You Ask
• Ex-Sonsini Atty Charged In $32M Insider Trading Case
• The FTC And State Health Care Regulation
• Cephalon Board Rejects Valeant's $5.7B Merger Bid
• Pfizer Securities Fraud Suit Must Stay In NJ: Judge
• Ortho Can't Shake False Marking Claims On 5 Drugs
• Galderma, Dermalogix End Clobex Suit Against Paddock
• 166 Plaintiffs Tossed From Neurontin MDL
• Fed. Circ. Mulls Smith & Nephew $5.2M Patent Win
• FTC Clears Cephalon's $225M Gemin X Buyout
• Palmetto Targets AstraZeneca's Crestor In IP Suit
• Hill-Rom Targets Stryker Over Bed, Stretcher Patents
• Comcast, Pepsi, Others Hit With Database Patent Suit
• Fried Frank Reps Merck In $430M Inspire Deal
• 7 Ways To Avoid Privacy And Data Security Trouble
• Eaton Sales Reps Seek $150M In Sex Bias Suit
• Lilly Sues Generics Maker Over Zyprexa Patent
• Lupin Unit Sues Ranbaxy Again Over Generic Antara
• Conceptus Fired Salesman For Overbilling Report: Suit
• Amgen Expert Report Allowed In Aranesp Kickback Suit
• Myriad Pushes For Isolated DNA Patents In Fed. Circ.
• Cubist, Teva Settle IP Suit Over Generic Cubicin
• NC Hospital To Pay $1.9M To End Medicare Fraud Suit
• Abbott, Elan Drop Tricor IP Suits Against Biovail
• Takeda Targets Dr. Reddy's Over Generic Dexilant
• Solvay Spreads Global Reach With $4.8B Rhodia Buy
• A Winning Strategy For Beating IPO Class Actions
• Taming Of The 'Ostrich Officers'
• Simpson Reps KKR In $2.4B Pfizer Capsule Unit Buy
• ReGen Using Menaflex IP After Rights Transfer: Suit
• BSC Poached Worker Suit To Move Forward In Calif.
• Fed. Circ. Restores Validity Of Can Construction IP
• Eurand, Anesta Sue Anchen Over Generic Amrix
• DOJ Sues Healthpoint Over Zenaderm Marketing
• Kwikset Ruling To Reignite False Ad Suits By Rivals
• Stryker Claims Zimmer Stole Employees
• Mintz Levin Lures Ober Kaler Health Antitrust Guru
• Allergan Sues Lupin Over Zymaxid Patents
• Drug Test Co. Lured Doctors With Kickbacks, Rival Says
• HIF, BizBiotech Must Face IP Claims In Federal Court
• Judge Denies Injunction In Animal Imaging IP Spat